Enjoy complimentary customisation on priority with our Enterprise License!
The antinuclear antibody test market size is estimated to grow by USD 392 million at a CAGR of 7.08% between 2023 and 2028. ANA (Antinuclear Antibody) tests have gained significant importance in the medical diagnostics industry due to the increasing prevalence of autoimmune diseases. The demand for ANA tests is on the rise as they are used to identify various autoimmune disorders such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Sjogren's syndrome. Furthermore, government initiatives to improve healthcare infrastructure and increase accessibility to diagnostic services have created a favorable environment for the growth of the ANA testing market. Additionally, the rising number of reagent rental agreements between diagnostic laboratories and test kit manufacturers has led to cost savings and increased efficiency in the testing process. These factors collectively contribute to the growing market for ANA tests and are expected to drive its growth in the coming years.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.